Focal adhesion kinase functions as an Akt downstream target in migration of colorectal cancer cells

Translational Oncology

Volumn 2, Issue 4, 2009, Pages 281-290

  Turečková, Jolana ^a   Vojtěchová, Martina ^a   Krausová, Michaela ^a   Šloncová, Eva ^a   Kořínek, Vladimír ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; FOCAL ADHESION KINASE; LENTIVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CELL MIGRATION; COLORECTAL CANCER; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77953457807     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09160     Document Type: Article

References (42)

1. Stetler-Stevenson WG, Aznavoorian S, and Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9, 541-573.
2. Moustakas A and Heldin CH (2007). Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98, 1512-1520.
3. Taniyama Y, Weber DS, Rocic P, Hilenski L, Akers ML, Park J, Hemmings BA, Alexander RW, and Griendling KK (2003). Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol 23, 8019-8029.
4. Geiger B, Bershadsky A, Pankov R, and Yamada KM (2001). Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2, 793-805.
5. Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, and Baba HA (2005). High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res 7, R194-R203.
6. Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED, Beggs HE, Reichardt LF, and Parsons JT (2005). Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. J Cell Sci 118, 2613-2623.
7. van Nimwegen MJ and van de Water B (2007). Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73, 597-609.
8. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, and Yamamoto T (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544.
9. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, and Cance WG (1995). Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55, 2752-2755.
10. Judson PL, He X, CanceWG, and Van Le L (1999). Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86, 1551-1556.
11. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, and Birchmeier W(1991). E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113, 173-185.
12. Sugiura Y, Shimada H, Seeger RC, Laug WE, and DeClerck YA (1998). Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58, 2209-2216.
13. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, and DeClerck YA (1994). Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54, 5467-5473.
14. Hua J and Muschel RJ (1996). Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res 56, 5279-5284.
15. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, and Hayakawa T (1992). Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267, 21712-21719.
16. Brazil DP and Hemmings BA (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26, 657-664.
17. Testa JR and Bellacosa A (2001). AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98, 10983-10985.
18. Manning BD and Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
19. Vojtechova M, Senigl F, Sloncova E, and Tuhackova Z (2006). Regulation of c-Src activity by the expression of wild-type v-Src and its kinase-dead double Y416FK295N mutant. Arch Biochem Biophys 455, 136-143.
20. Tureckova J,Wilson EM,Cappalonga JL, andRotwein P (2001). Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276, 39264-39270.
21. Kohn AD, Barthel A, Kovacina KS, Boge A,Wallach B, Summers SA, Birnbaum MJ, Scott PH, Lawrence JC Jr, and Roth RA (1998). Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273, 11937-11943.
22. Bar-Peled M and Raikhel NV (1996). A method for isolation and purification of specific antibodies to a protein fused to the GST. Anal Biochem 241, 140-142.
23. Roca F,Mauro LV,Morandi A, Bonadeo F,VaccaroC,QuintanaGO, Specterman S, de Kier Joffe EB, Pallotta MG, Puricelli LI, et al. (2006). Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma. J Surg Oncol 93, 151-160.
24. Noritake J, Watanabe T, Sato K, Wang S, and Kaibuchi K (2005). IQGAP1: a key regulator of adhesion and migration. J Cell Sci 118, 2085-2092.
25. Kurokawa K, Nakamura T, Aoki K, and Matsuda M (2005). Mechanism and role of localized activation of Rho-family GTPases in growth factor-stimulated fibroblasts and neuronal cells. Biochem Soc Trans 33, 631-634.
26. Moldovan GL, Pfander B, and Jentsch S (2007). PCNA, the maestro of the replication fork. Cell 129, 665-679.
27. Sieg DJ, Hauck CR, and Schlaepfer DD (1999). Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 112 (Pt 16), 2677-2691.
28. Oneyama C, Hikita T, Nada S, and Okada M (2008). Functional dissection of transformation by c-Src and v-Src. Genes Cells 13, 1-12.
29. Gabarra-Niecko V, Keely PJ, and Schaller MD (2002). Characterization of an activated mutant of focal adhesion kinase: "SuperFAK". Biochem J 365, 591-603.
30. Rodina A, Schramm K, Musatkina E, Kreuser ED, Tavitian A, and Tatosyan A (1999). Phosphorylation of p125FAK and paxillin focal adhesion proteins in srctransformed cells with different metastatic capacity. FEBS Lett 455, 145-148.
31. Summy JM and Gallick GE (2003). Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22, 337-358.
32. KleinmanHK,McGarveyML, Liotta LA,Robey PG,TryggvasonK, andMartinGR (1982). Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21, 6188-6193.
33. Johansson N, Ahonen M, and Kahari VM (2000). Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 57, 5-15.
34. Siddiqui KM and Chopra DP (1984). Primary and long term epithelial cell cultures from human fetal normal colonic mucosa. In Vitro 20, 859-868.
35. Sovova V, Sloncova E, and Fric P (1997). Differences of alkaline phosphatase and arginase activities in human colorectal carcinoma cell lines. Folia Biol (Praha) 43, 101-104.
36. Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, and Mabry ND (1976). Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36, 4562-4569.
37. Lobo M and Zachary I (2000). Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. Biochem Biophys Res Commun 276, 1068-1074.
38. Heidkamp MC, Bayer AL, Kalina JA, Eble DM, and Samarel AM (2002). GFPFRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes. Circ Res 90, 1282-1289.
39. Higuchi M, Masuyama N, Fukui Y, Suzuki A, and Gotoh Y (2001). Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells. Curr Biol 11, 1958-1962.
40. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, et al. (2003). Differential regulation of cell motility and invasion by FAK. J Cell Biol 160, 753-767.
41. Larue L and Bellacosa A (2005). Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3? kinase/AKT pathways. Oncogene 24, 7443-7454.
42. Leslie NR and Downes CP (2002). PTEN: the down side of PI 3-kinase signalling. Cell Signal 14, 285-295.